iRadimed Corporation (IRMD)
NASDAQ
Closed
Oct 23, 2026
Day's Range
85.4652 wk Range
75.75Overview - IRMD - iRadimed Corporation
Key Statistics
Valuation
Enterprise Value
1.08B
P/E (Trailing)
51.12
P/E (Forward)
36.46
PEG Ratio
-5.75
Price / Sales (TTM)
13.25
Price / Book
11.24
EV / EBITDA
37.17
Profitability
Gross Margin
74.07%
Profit Margin
26.70%
Operating Margin
31.22%
Return on Assets
15.55%
Return on Equity
23.52%
Ownership
Shares Outstanding
12.78M
Float
8.33M
Short % of Shares Outstanding
7.93%
Held by Insiders
35.18%
Held by Institutions
62.66%
Price stats
Beta
0.91
50-Day Avg
86.49
200-Day Avg
93.37
Dividends
Payout Ratio
41.34%
Frequency
Quarterly
Analyst Consensus
3 analysts
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - IRMD - iRadimed Corporation
Peers - IRMD - iRadimed Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - IRMD - iRadimed Corporation
About
iRadimed Corporation is a medical device company that develops, manufactures, markets, and distributes MRI-compatible patient care solutions. Its product portfolio includes MRI-compatible intravenous infusion pump systems, patient vital signs monitoring systems, ferromagnetic detection devices, and related accessories…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
